Alnylam Pharmaceuticals
ALNY
#728
Rank
NZ$60.12 B
Marketcap
NZ$449.33
Share price
-1.08%
Change (1 day)
-40.88%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company